30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
France Biotechnology & Medical Research

Genfit SA (GNFT)

Track

The most recent insider transaction at Genfit SA occurred on February 27, 2026, when the COO sold shares valued at $266,187.89. Prior to this, several buy transactions were noted in July 2023, primarily by executives including the President of the Board and the CEO, indicating previous insider confidence.
Stock chart
Ticker: GNFT Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
PASCAL CAISEY
COO
1 sale — total 266,188 EUR
Sale 27 Feb 2026
Value €1,992,802.50 | Price 184.95 | Shares 59,647
Buy 7 Jul 2023
Value €34,923.65 | Price 64.08 | Shares 93,734
Buy 6 Jul 2023
Value €36,960.00 | Price 3.70 | Shares 10,000
Buy 5 Jul 2023
Value €37,061.00 | Price 3.71 | Shares 10,000
Buy 3 Jul 2023
Value €18,769.95 | Price 3.54 | Shares 5,300
Buy 3 Mar 2022
Value €34,912.00 | Price 3.49 | Shares 10,000
Buy 2 Mar 2022
Value €34,200.00 | Price 3.42 | Shares 10,000
Buy 13 May 2020
Value €46,981.96 | Price 6.71 | Shares 7,000
Buy 13 May 2020
Value €47,838.00 | Price 7.14 | Shares 6,700
Buy 14 Dec 2017
Value €1,849,992.60 | Price 22.20 | Shares 83,333
Buy 24 Oct 2017
Value €42,504.00 | Price 21.25 | Shares 2,000
Sale 20 Oct 2016
Value €737,576.91 | Price 0.50 | Shares 1,461,127
Buy 20 Oct 2016
Value €491,676.90 | Price 14.30 | Shares 34,383
Buy 15 Jun 2015
Value €101,160.00 | Price 33.72 | Shares 3,000
Buy 27 Apr 2015
Value €201,069.75 | Price 38.30 | Shares 5,250
Sale 4 Nov 2014
Value €20,778,000.00 | Price 34.63 | Shares 600,000
Sale 1 Oct 2014
Value €6,062,462.80 | Price 42.69 | Shares 142,000
Sale 23 Jul 2014
Value €12,589,500.00 | Price 27.25 | Shares 462,000
Sale 23 Jul 2014
Value €12,589,500.00 | Price 23.25 | Shares 541,484
Sale 17 Jul 2014
Value €392,500.00 | Price 29.07 | Shares 13,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2026-02-27 S Sale
PASCAL CAISEY

COO

Officer
59,647
184.95
€1,992,802 		59,647 184.95 €1,992,802
2023-07-11 2023-07-07 B Purchase
1.1
jean francois tine

administrateur

Director
93,734
64.08
€34,924 		93,734 64.08 €34,924
2023-07-06 2023-07-06 B Purchase
3.1
Jean-François MOUNEY

Président du Conseil d'Administration

Director
83,886
388.05
€3,834,116 		83,886 388.05 €3,834,116
2023-07-06 2023-07-05 B Purchase
1.6
Pascal Prigent

Directeur Général

Officer
10,000
3.71
€37,061 		10,000 3.71 €37,061
2023-07-05 2023-07-03 B Purchase
1.1
jean francois tine

administrateur

Director
5,300
3.54
€18,770 		5,300 3.54 €18,770
2022-03-07 2022-03-03 B Purchase
1.6
Pascal Prigent

Directeur Général

Officer
10,000
3.49
€34,912 		10,000 3.49 €34,912
2022-03-07 2022-03-02 B Purchase
3.1
Jean-François MOUNEY

Président du Conseil d'Administration

Director
10,000
3.42
€34,200 		10,000 3.42 €34,200
2020-05-18 2020-05-13 B Purchase
3.1
Jean-François MOUNEY

Président du Conseil d'Administration

Director
7,000
6.71
€46,982 		7,000 6.71 €46,982
2020-05-18 2020-05-13 B Purchase
1.6
Pascal Prigent

Directeur Général

Officer
6,700
7.14
€47,838 		6,700 7.14 €47,838
2017-12-19 2017-12-14 B Purchase SAS BIOTECH AVENIR SAS

Membre du Conseil d'Administration

Director
83,333
22.20
€1,849,993 		83,333 22.20 €1,849,993
2017-10-26 2017-10-24 B Purchase
3.1
Jean-François MOUNEY

Président Directeur Général

Executive Director
2,000
21.25
€42,504 		2,000 21.25 €42,504
2016-10-26 2016-10-20 S Sale
3.1
MOUNEY Jean-François SAS

Membre du Conseil de Surveillance

Supervisory Board Member
1,461,127
0.50
€737,577 		1,461,127 0.50 €737,577
2016-10-26 2016-10-20 B Purchase SAS BIOTECH AVENIR

Membre du Conseil de Surveillance

Supervisory Board Member
34,383
14.30
€491,677 		34,383 14.30 €491,677
2015-06-18 2015-06-15 B Purchase
3.1
Jean-François MOUNEY

Président du Directoire

Management Board Member
3,000
33.72
€101,160 		3,000 33.72 €101,160
2015-04-30 2015-04-27 B Purchase
3.1
Jean-François MOUNEY

Président du Directoire

Management Board Member
5,250
38.30
€201,070 		5,250 38.30 €201,070
2014-11-15 2014-11-04 S Sale SAS BIOTECH AVENIR

Membre du Conseil de Surveillance

Supervisory Board Member
600,000
34.63
€20,778,000 		600,000 34.63 €20,778,000
2014-10-10 2014-10-01 S Sale SAS BIOTECH AVENIR

Membre du Conseil de Surveillance

Supervisory Board Member
142,000
42.69
€6,062,463 		142,000 42.69 €6,062,463
2014-08-04 2014-07-23 S Sale SAS BIOTECH AVENIR

Membre du Conseil de Surveillance

Supervisory Board Member
462,000
27.25
€12,589,500 		462,000 27.25 €12,589,500
2014-07-31 2014-07-23 S Sale SAS BIOTECH AVENIR

Membre du Conseil de Surveillance

Supervisory Board Member
541,484
23.25
€12,589,500 		541,484 23.25 €12,589,500
2014-07-25 2014-07-17 S Sale
3.1
Jean-François MOUNEY

Président du Directoire

Management Board Member
13,500
29.07
€392,500 		13,500 29.07 €392,500
Explore more

More insider trading research around Genfit SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe